Switzerland· 67774002
Dermafusone
A betamethason und antibiotika product containing acidum fusidicum, betamethasonum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Betamethason und antibiotika is registered in 9 of 19 countries.
Countries holding a registration under ATC D07CC01 (betamethason und antibiotika), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 6 of them publish a price we can compare per daily dose
Betamethason und antibiotika · ATC D07CC01
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- acidum fusidicum, betamethasonum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- D07CC01
- ATC class
- Betamethason und Antibiotika
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680677740022Tb 30 gCHF 25.7
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Betamethason und antibiotika in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainBEFUDIN 20 MG/G + 1 MG/G CREMALaboratoires Medgen
- United KingdomBetamethasone valerate 0.1% / Fusidic acid 2% creamPerennial Pharma Ltd
- IrelandFucibet 20 mg/g + 1 mg/g creamLeo Laboratories Limited
- GermanyBetagalen Plus FusidinsäureGalenpharma Gmbh
- CzechiaIMAXEMALaboratoires Bailleul S.A., Luxembourg
- PolandDermisilZakłady Farmaceutyczne POLPHARMA S.A.
- FinlandAddicortStrides Nordic ApS
- CanadaFUCIBETLEO PHARMA INC
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Fucibet Lipid, Fusicutan
- Belgium · Atosene, Defucort
- Bulgaria · Бетафузин, Фусибет Липид
- Cyprus · Betacort, Betafusin
- Czechia · Fucicort, Imaxema
- Germany · Betagalen Plus Fusidinsäure, Fucicort®
- Denmark · Fucicort, Fucicort Lipid
- Estonia · Fucicort
- Spain · Befudin, Cortifusin
- Finland · Addicort, Fucicort
- France · Dermafusone
- United Kingdom (Northern Ireland) · Fucibet, Fusidic Acid & Betamethasone Generics [uk]
- Greece · Alpider, Bet-Fu
- Hungary · Fucicort, Metafuzin
- Ireland · Fucibet, Fucibet®
- Italy · Fucicort, Fucimixbeta
- Lithuania · Enosat, Fucicort
- Luxembourg · Atosene, Defucort
- Latvia · Enosat, Fucicort
- Malta · Cortofusin, Fucibet®
- Norway · Addicort
- Poland · Dermisil, Fucibet Lipid
- Portugal · Betametasona + Ácido Fusídico Mylan, Fucicort
- Romania · Fucicort, Imaxema
- Sweden · Addicort
- Slovakia · Fucicort, Imaxema
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af68db1f-98ae-4322-be8d-9190127a602c GET /v1/drugs/af68db1f-98ae-4322-be8d-9190127a602c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "acidum fusidicum 20 mg + betamethasonum 1 mg",
"valid_from": "2025-05-01",
"limitations": null,
"galenic_form": "Creme 2%",
"therapeutic_area": null,
"sl_inclusion_date": "2025-05-01",
"self_retention_pct": 10
}See everything about betamethason und antibiotika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.